{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:36:56Z","timestamp":1786552616903,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Elite Medical Professionals Project of China-Japan Friendship Hospital","award":["NO.ZRJY2025-QMPY28"],"award-info":[{"award-number":["NO.ZRJY2025-QMPY28"]}]},{"name":"National Key Clinical Specialty Construction Project","award":["2024-QTL-001"],"award-info":[{"award-number":["2024-QTL-001"]}]},{"name":"Science and Technology Innovation Key R&D Program of Chongqing","award":["CSTB2022TIAD-STX0008"],"award-info":[{"award-number":["CSTB2022TIAD-STX0008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Orthop Trauma Surg"],"DOI":"10.1007\/s00402-026-06419-9","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:43:12Z","timestamp":1786549392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of primary tumor surgery with survival outcomes in patients with bone metastases across multiple cancer types"],"prefix":"10.1007","volume":"146","author":[{"given":"Pei-Hang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bochong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wending","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiluo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangjun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"6419_CR1","first-page":"004","volume":"15","author":"S D\u2019Oronzo","year":"2019","unstructured":"D\u2019Oronzo S, Coleman R, Brown J, Silvestris F (2019) Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management. J Bone Oncol 15:004\u2013004","journal-title":"J Bone Oncol"},{"key":"6419_CR2","doi-asserted-by":"publisher","first-page":"e0234927","DOI":"10.1371\/journal.pone.0234927","volume":"15","author":"S Hong","year":"2020","unstructured":"Hong S, Youk T, Lee SJ, Kim KM, Vajdic CM (2020) Bone metastasis and skeletal-related events in patients with solid cancer: a Korean nationwide health insurance database study. PLoS ONE 15:e0234927","journal-title":"PLoS ONE"},{"key":"6419_CR3","doi-asserted-by":"publisher","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s\u20136249s","journal-title":"Clin Cancer Res"},{"key":"6419_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","volume":"6","author":"RE Coleman","year":"2020","unstructured":"Coleman RE, Croucher PI, Padhani AR, Cl\u00e9zardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R, Costa L (2020) Bone metastases. Nat Rev Dis Primers 6:83","journal-title":"Nat Rev Dis Primers"},{"key":"6419_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12885-020-06739-y","volume":"20","author":"H Song","year":"2020","unstructured":"Song H, Jin S, Xiang P, Hu S, Jin J (2020) Prognostic value of the bone scan index in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. BMC Cancer 20:238","journal-title":"BMC Cancer"},{"key":"6419_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2967\/jnumed.114.146936","volume":"56","author":"EY Yu","year":"2015","unstructured":"Yu EY, Duan F, Muzi M, Deng X, Chin BB, Alumkal JJ, Taplin ME, Taub JM, Herman B, Higano CS et al (2015) Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687. J Nucl Med 56:354\u2013360","journal-title":"J Nucl Med"},{"key":"6419_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrd3705","volume":"11","author":"DL Lacey","year":"2012","unstructured":"Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, Sullivan JK, San Martin J, Dansey R (2012) Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov 11:401\u2013419","journal-title":"Nat Rev Drug Discov"},{"key":"6419_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/sj.bjc.6601663","volume":"90","author":"JJ Body","year":"2004","unstructured":"Body JJ, Diel IJ, Lichinitzer M, Lazarev A, Pecherstorfer M, Bell R, Tripathy D, Bergstrom B (2004) Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies. Br J Cancer 90:1133\u20131137","journal-title":"Br J Cancer"},{"key":"6419_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejca.2015.09.011","volume":"53","author":"A Lipton","year":"2016","unstructured":"Lipton A, Fizazi K, Stopeck AT, Henry DH, Smith MR, Shore N, Martin M, Vadhan-Raj S, Brown JE, Richardson GE et al (2016) Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics. Eur J Cancer 53:75\u201383","journal-title":"Eur J Cancer"},{"key":"6419_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1302\/2058-5241.1.000008","volume":"1","author":"JJ Willeumier","year":"2016","unstructured":"Willeumier JJ, van der Linden YM, van de Sande MAJ, Dijkstra PDS (2016) Treatment of pathological fractures of the long bones. EFORT Open Rev 1:136\u2013145","journal-title":"EFORT Open Rev"},{"key":"6419_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejso.2019.08.019","volume":"46","author":"AC Disch","year":"2020","unstructured":"Disch AC, Kleber C, Redemann D, Druschel C, Liljenqvist U, Schaser KD (2020) Current surgical strategies for treating spinal tumors: results of a questionnaire survey among members of the German Spine Society (DWG). Eur J Surg Oncol 46:89\u201394","journal-title":"Eur J Surg Oncol"},{"key":"6419_CR12","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.21873\/anticanres.16957","volume":"44","author":"N Kitsuya","year":"2024","unstructured":"Kitsuya N, Matsuoka M, Onodera T, Yokota I, Iwasaki K, Suzuki Y, Hamasaki M, Kondo E, Iwasaki N (2024) Surgical resection of primary tumor for bone metastatic breast cancer patients at initial presentation. Anticancer Res 44:1591\u20131601","journal-title":"Anticancer Res"},{"key":"6419_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/ans.12548","volume":"85","author":"J Rhu","year":"2015","unstructured":"Rhu J, Lee SK, Kil WH, Lee JE, Nam SJ (2015) Surgery of primary tumour has survival benefit in metastatic breast cancer with single-organ metastasis, especially bone. ANZ J Surg 85:240\u2013244","journal-title":"ANZ J Surg"},{"key":"6419_CR14","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/jso.26773","volume":"125","author":"MT Congedo","year":"2022","unstructured":"Congedo MT, Nachira D, Bertolaccini L, Chiappetta M, Zanfrini E, Meacci E, Vita ML, Lococo F, D\u2019Argento E, Spaggiari L, Margaritora S (2022) Multimodal therapy for synchronous bone oligometastatic NSCLC: the role of surgery. J Surg Oncol 125:782\u2013789","journal-title":"J Surg Oncol"},{"key":"6419_CR15","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3389\/fonc.2019.01495","volume":"9","author":"P Xu","year":"2019","unstructured":"Xu P, Wang J, Abudurexiti M, Jin S, Wu J, Shen Y, Ye D (2019) Prognosis of patients with testicular carcinoma is dependent on metastatic site. Front Oncol 9:1495","journal-title":"Front Oncol"},{"key":"6419_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/CMAR.S148856","volume":"9","author":"F Dong","year":"2017","unstructured":"Dong F, Shen Y, Gao F, Xu T, Wang X, Zhang X, Zhong S, Zhang M, Chen S, Shen Z (2017) Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study. Cancer Manag Res 9:611\u2013626","journal-title":"Cancer Manag Res"},{"key":"6419_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/1759-7714.14801","volume":"14","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Gao Y, Tan F, Xue Q, Gao S, He J (2023) Specific organ metastases and prognosis in lung adenocarcinoma. Thorac Cancer 14:736\u2013745","journal-title":"Thorac Cancer"},{"key":"6419_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00345-016-1906-3","volume":"35","author":"R Mathieu","year":"2017","unstructured":"Mathieu R, Korn SM, Bensalah K, Kramer G, Shariat SF (2017) Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense? World J Urol 35:567\u2013577","journal-title":"World J Urol"},{"key":"6419_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21037\/atm-20-4764","volume":"9","author":"W Wu","year":"2021","unstructured":"Wu W, Zhang H, Fang Z, Li F (2021) Primary tumor surgery improves survival of cancer patients with synchronous solitary bone metastasis: a large population-based study. Ann Transl Med 9:31","journal-title":"Ann Transl Med"},{"key":"6419_CR20","doi-asserted-by":"publisher","first-page":"e23132","DOI":"10.1097\/MD.0000000000023132","volume":"99","author":"W Ding","year":"2020","unstructured":"Ding W, Ruan G, Zhu J, Tu C, Li Z (2020) Metastatic site discriminates survival benefit of primary tumor surgery for differentiated thyroid cancer with distant metastases: a real-world observational study. Med (Baltim) 99:e23132","journal-title":"Med (Baltim)"},{"key":"6419_CR21","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1200\/JCO.2005.04.2226","volume":"24","author":"E Rapiti","year":"2006","unstructured":"Rapiti E, Verkooijen HM, Vlastos G, Fioretta G, Neyroud-Caspar I, Sappino AP, Chappuis PO, Bouchardy C (2006) Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 24:2743\u20132749","journal-title":"J Clin Oncol"},{"key":"6419_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.lungcan.2018.11.012","volume":"129","author":"Z Sun","year":"2019","unstructured":"Sun Z, Sui X, Yang F, Wang J (2019) Effects of primary tumor resection on the survival of patients with stage IV extrathoracic metastatic non-small cell lung cancer: a population-based study. Lung Cancer 129:98\u2013106","journal-title":"Lung Cancer"},{"key":"6419_CR23","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/ejcts\/ezaa005","volume":"57","author":"M Casiraghi","year":"2020","unstructured":"Casiraghi M, Bertolaccini L, Sedda G, Petrella F, Galetta D, Guarize J, Maisonneuve P, De Marinis F, Spaggiari L (2020) Lung cancer surgery in oligometastatic patients: outcome and survival. Eur J Cardiothorac Surg 57:1173\u20131180","journal-title":"Eur J Cardiothorac Surg"},{"key":"6419_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.euo.2019.06.014","volume":"3","author":"M Moschini","year":"2020","unstructured":"Moschini M, Xylinas E, Zamboni S, Mattei A, Niegisch G, Yu EY, Bamias A, Agarwal N, Sridhar SS, Sternberg CN et al (2020) Efficacy of surgery in the primary tumor site for metastatic urothelial cancer: analysis of an international, multicenter, multidisciplinary database. Eur Urol Oncol 3:94\u2013101","journal-title":"Eur Urol Oncol"},{"key":"6419_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.eururo.2018.09.008","volume":"75","author":"LMS Boev\u00e9","year":"2019","unstructured":"Boev\u00e9 LMS, Hulshof M, Vis AN, Zwinderman AH, Twisk JWR, Witjes WPJ, Delaere KPJ, Moorselaar R, Verhagen P, van Andel G (2019) Effect on survival of androgen deprivation therapy alone compared to androgen deprivation therapy combined with concurrent radiation therapy to the prostate in patients with primary bone metastatic prostate cancer in a prospective randomised clinical trial: data from the HORRAD trial. Eur Urol 75:410\u2013418","journal-title":"Eur Urol"},{"key":"6419_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/ijc.31034","volume":"142","author":"M Lagendijk","year":"2018","unstructured":"Lagendijk M, van Maaren MC, Saadatmand S, Strobbe LJA, Poortmans PMP, Koppert LB, Tilanus-Linthorst MMA, Siesling S (2018) Breast conserving therapy and mastectomy revisited: breast cancer-specific survival and the influence of prognostic factors in 129,692 patients. Int J Cancer 142:165\u2013175","journal-title":"Int J Cancer"},{"key":"6419_CR27","doi-asserted-by":"publisher","first-page":"e19279","DOI":"10.1097\/MD.0000000000019279","volume":"99","author":"H Qiu","year":"2020","unstructured":"Qiu H, Xu WH, Kong J, Ding XJ, Chen DF (2020) Effect of breast-conserving surgery and modified radical mastectomy on operation index, symptom checklist-90 score and prognosis in patients with early breast cancer. Med (Baltim) 99:e19279","journal-title":"Med (Baltim)"},{"key":"6419_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.lungcan.2022.08.013","volume":"172","author":"G Stamatis","year":"2022","unstructured":"Stamatis G, Leschber G, Schwarz B, Brintrup DL, Flossdorf S, Passlick B, Hecker E, Kugler C, Eichhorn M, Krbek T et al (2022) Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2\u00a0cm. Lung Cancer 172:108\u2013116","journal-title":"Lung Cancer"},{"key":"6419_CR29","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.jtcvs.2019.10.165","volume":"159","author":"SS Razi","year":"2020","unstructured":"Razi SS, Nguyen D, Villamizar N (2020) Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease. J Thorac Cardiovasc Surg 159:2469\u20132483e2464","journal-title":"J Thorac Cardiovasc Surg"},{"key":"6419_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","volume":"366","author":"RA Patchell","year":"2005","unstructured":"Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366:643\u2013648","journal-title":"Lancet"},{"key":"6419_CR31","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3171\/jns.1978.49.6.0839","volume":"49","author":"KE Livingston","year":"1978","unstructured":"Livingston KE, Perrin RG (1978) The neurosurgical management of spinal metastases causing cord and cauda equina compression. J Neurosurg 49:839\u2013843","journal-title":"J Neurosurg"},{"key":"6419_CR32","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/SLA.0b013e3181efc635","volume":"252","author":"O Al-Sahaf","year":"2010","unstructured":"Al-Sahaf O, Wang JH, Browne TJ, Cotter TG, Redmond HP (2010) Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung. Ann Surg 252:1037\u20131043","journal-title":"Ann Surg"},{"issue":"Suppl","key":"6419_CR33","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.3816\/CBC.2005.s.004","volume":"5","author":"TA Guise","year":"2005","unstructured":"Guise TA, Kozlow WM, Heras-Herzig A, Padalecki SS, Yin JJ, Chirgwin JM (2005) Molecular mechanisms of breast cancer metastases to bone. Clin Breast Cancer 5(Suppl):S46\u201353","journal-title":"Clin Breast Cancer"},{"key":"6419_CR34","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.surg.2011.02.005","volume":"149","author":"Y Takemoto","year":"2011","unstructured":"Takemoto Y, Li TS, Kubo M, Ohshima M, Ueda K, Harada E, Enoki T, Okamoto M, Mizukami Y, Murata T, Hamano K (2011) Operative injury accelerates tumor growth by inducing mobilization and recruitment of bone marrow-derived stem cells. Surgery 149:792\u2013800","journal-title":"Surgery"},{"key":"6419_CR35","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1158\/1541-7786.MCR-10-0264","volume":"8","author":"Diamandis Maria","year":"2010","unstructured":"Diamandis M, White NM, Yousef GM: Personalized medicine: marking a new epoch in cancer patient management. Mol Cancer Res 2010, 8:1175-1187.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"6419_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.metabol.2012.08.016","volume":"62","author":"M Kalia","year":"2013","unstructured":"Kalia M: Personalized oncology: recent advances and future challenges. Metabolism 2013, 62 Suppl 1:S11-14.","journal-title":"Metabolism"}],"container-title":["Archives of Orthopaedic and Trauma Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-026-06419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00402-026-06419-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-026-06419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:43:14Z","timestamp":1786549394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00402-026-06419-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6419"],"URL":"https:\/\/doi.org\/10.1007\/s00402-026-06419-9","relation":{},"ISSN":["1434-3916"],"issn-type":[{"value":"1434-3916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for ethical approval and informed consent was formally waived by the Medical Ethics Committee of Fudan University Shanghai Cancer Center (SCCIRB) in accordance with Article 32 of the Measures for Ethical Review of Life Science and Medical Research Involving Humans of the National Health Commission of China and the Declaration of Helsinki. The waiver approval number is 2409-No.001 (Version B-16, 2024.08.30). The study was registered in the Chinese Clinical Trial Registry (ChiCTR2400090161).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as this study used de-identified data from a public database and did not include any individual person\u2019s data.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"298"}}